Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giannakis

Showing results (461-470 of 518) with videos related to

Pageof 52
Sort By:
BMC Genomics|April 25, 2024
Germline genetic regulation of the colorectal tumor immune microenvironmentStephanie L Schmit, Ya-Yu Tsai, Joseph D Bonner, et al.
Nature|February 28, 2020
Mutational signature in colorectal cancer caused by genotoxic pks<sup>+</sup> E. coliCayetano Pleguezuelos-Manzano, Jens Puschhof, Axel Rosendahl Huber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
The Journal of Pathology|December 28, 2019
Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancerKoichiro Haruki, Keisuke Kosumi, Tsuyoshi Hamada, et al.
Nature Genetics|July 13, 2021
Genome-scale screens identify factors regulating tumor cell responses to natural killer cellsMichal Sheffer, Emily Lowry, Nicky Beelen, et al.
The Journal of Clinical Investigation|November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, Andrew Portell, Elena V Ivanova, et al.
Cancer Immunology Research|May 28, 2015
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 ActivationEliezer M Van Allen, Hadrien G Golay, Yan Liu, et al.
Clinical and Translational Gastroenterology|November 5, 2016
Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor LocationKosuke Mima, Yin Cao, Andrew T Chan, et al.
Nature Genetics|June 28, 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasisWilliam J Gibson, Erling A Hoivik, Mari K Halle, et al.
Cancer Immunology Research|September 20, 2018
<i>Fusobacterium nucleatum</i> in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability StatusTsuyoshi Hamada, Xuehong Zhang, Kosuke Mima, et al.
Pageof 52

Showing results (461-470 of 518) with videos related to

Sort By:
Pageof 52
BMC Genomics|April 25, 2024
Germline genetic regulation of the colorectal tumor immune microenvironmentStephanie L Schmit, Ya-Yu Tsai, Joseph D Bonner, et al.
Nature|February 28, 2020
Mutational signature in colorectal cancer caused by genotoxic pks<sup>+</sup> E. coliCayetano Pleguezuelos-Manzano, Jens Puschhof, Axel Rosendahl Huber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2023
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic AdenocarcinomaBrandon M Huffman, Hanrong Feng, Kalindi Parmar, et al.
The Journal of Pathology|December 28, 2019
Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancerKoichiro Haruki, Keisuke Kosumi, Tsuyoshi Hamada, et al.
Nature Genetics|July 13, 2021
Genome-scale screens identify factors regulating tumor cell responses to natural killer cellsMichal Sheffer, Emily Lowry, Nicky Beelen, et al.
The Journal of Clinical Investigation|November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, Andrew Portell, Elena V Ivanova, et al.
Cancer Immunology Research|May 28, 2015
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 ActivationEliezer M Van Allen, Hadrien G Golay, Yan Liu, et al.
Clinical and Translational Gastroenterology|November 5, 2016
Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor LocationKosuke Mima, Yin Cao, Andrew T Chan, et al.
Nature Genetics|June 28, 2016
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasisWilliam J Gibson, Erling A Hoivik, Mari K Halle, et al.
Cancer Immunology Research|September 20, 2018
<i>Fusobacterium nucleatum</i> in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability StatusTsuyoshi Hamada, Xuehong Zhang, Kosuke Mima, et al.
Pageof 52